Clinical trial
Efficacy of Topical Cyclosporine 0.05% in the Prevention of Ocular Surface…
NCT00383396 · Innovative Medical, Industry · Completed
Key facts
| NCT number | NCT00383396 |
|---|---|
| Title | Efficacy of Topical Cyclosporine 0.05% in the Prevention of Ocular Surface Inflammation Secondary to Pterygia |
| Lead sponsor | Innovative Medical, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Pterygia |
| Intervention type | Drug |
| Interventions | Topical Cyclosporine |
| First posted | Oct 3, 2006 |
| Last update posted | Feb 13, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: